You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

NEUROLITE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Neurolite, and when can generic versions of Neurolite launch?

Neurolite is a drug marketed by Lantheus Medcl and is included in one NDA.

The generic ingredient in NEUROLITE is technetium tc-99m bicisate kit. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m bicisate kit profile page.

US Patents and Regulatory Information for NEUROLITE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lantheus Medcl NEUROLITE technetium tc-99m bicisate kit INJECTABLE;INJECTION 020256-001 Nov 23, 1994 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for NEUROLITE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lantheus Medcl NEUROLITE technetium tc-99m bicisate kit INJECTABLE;INJECTION 020256-001 Nov 23, 1994 ⤷  Try a Trial ⤷  Try a Trial
Lantheus Medcl NEUROLITE technetium tc-99m bicisate kit INJECTABLE;INJECTION 020256-001 Nov 23, 1994 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for NEUROLITE

See the table below for patents covering NEUROLITE around the world.

Country Patent Number Title Estimated Expiration
South Africa 8801136 ⤷  Try a Trial
New Zealand 223552 ESTER-SUBSTITUTED DIAMINEDITHIOLS AND RADIOLABELLED COMPLEXES AND USE THEREOF ⤷  Try a Trial
Japan H0764802 ⤷  Try a Trial
South Korea 920002167 ⤷  Try a Trial
Germany 3871173 ⤷  Try a Trial
Japan S63295549 ESTER SUBSTITUTED DIAMINEDITHIOLS AND RADIOACTIVE LABELED COMPLEX COMPOUND ⤷  Try a Trial
Australia 614276 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for NEUROLITE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1178838 300736 Netherlands ⤷  Try a Trial PRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119
0279417 95C0005 Belgium ⤷  Try a Trial PRODUCT NAME: DICHLORHYDRATE DE BICISATE; NATIONAL REGISTRATION NO/DATE: 923 IS 16 F 12 19950316; FIRST REGISTRATION: DK DK.R.11. 931008 19931008
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.